Q&A: Perry Nisen

• Autores: Eric Bender
• Localización: Nature: International weekly journal of science, ISSN 0028-0836, Vol. 527, Nº Extra 7576, 2015, págs. 18-18
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • A former paediatric oncologist and molecular biologist with experience in academia and industry, Perry Nisen was senior vice-president for science and innovation at GlaxoSmithKline in 2014 before becoming chief executive at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California. He discusses the challenges facing drug discovery in the era of big data.